196 related articles for article (PubMed ID: 35945217)
1. MYC sensitises cells to apoptosis by driving energetic demand.
Edwards-Hicks J; Su H; Mangolini M; Yoneten KK; Wills J; Rodriguez-Blanco G; Young C; Cho K; Barker H; Muir M; Guerrieri AN; Li XF; White R; Manasterski P; Mandrou E; Wills K; Chen J; Abraham E; Sateri K; Qian BZ; Bankhead P; Arends M; Gammoh N; von Kriegsheim A; Patti GJ; Sims AH; Acosta JC; Brunton V; Kranc KR; Christophorou M; Pearce EL; Ringshausen I; Finch AJ
Nat Commun; 2022 Aug; 13(1):4674. PubMed ID: 35945217
[TBL] [Abstract][Full Text] [Related]
2. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction.
Wise DR; DeBerardinis RJ; Mancuso A; Sayed N; Zhang XY; Pfeiffer HK; Nissim I; Daikhin E; Yudkoff M; McMahon SB; Thompson CB
Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18782-7. PubMed ID: 19033189
[TBL] [Abstract][Full Text] [Related]
3. c-Myc programs fatty acid metabolism and dictates acetyl-CoA abundance and fate.
Edmunds LR; Sharma L; Kang A; Lu J; Vockley J; Basu S; Uppala R; Goetzman ES; Beck ME; Scott D; Prochownik EV
J Biol Chem; 2014 Sep; 289(36):25382-92. PubMed ID: 25053415
[TBL] [Abstract][Full Text] [Related]
4. SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma.
Jeong SM; Lee A; Lee J; Haigis MC
J Biol Chem; 2014 Feb; 289(7):4135-44. PubMed ID: 24368766
[TBL] [Abstract][Full Text] [Related]
5. ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation.
Qing G; Li B; Vu A; Skuli N; Walton ZE; Liu X; Mayes PA; Wise DR; Thompson CB; Maris JM; Hogarty MD; Simon MC
Cancer Cell; 2012 Nov; 22(5):631-44. PubMed ID: 23153536
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targeting of Myc-reprogrammed cancer cell metabolism.
Dang CV
Cold Spring Harb Symp Quant Biol; 2011; 76():369-74. PubMed ID: 21960526
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth.
Gaglio D; Metallo CM; Gameiro PA; Hiller K; Danna LS; Balestrieri C; Alberghina L; Stephanopoulos G; Chiaradonna F
Mol Syst Biol; 2011 Aug; 7():523. PubMed ID: 21847114
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC.
Liu W; Le A; Hancock C; Lane AN; Dang CV; Fan TW; Phang JM
Proc Natl Acad Sci U S A; 2012 Jun; 109(23):8983-8. PubMed ID: 22615405
[TBL] [Abstract][Full Text] [Related]
9. c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry.
Morrish F; Isern N; Sadilek M; Jeffrey M; Hockenbery DM
Oncogene; 2009 Jul; 28(27):2485-91. PubMed ID: 19448666
[TBL] [Abstract][Full Text] [Related]
10. MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer.
Shajahan-Haq AN; Cook KL; Schwartz-Roberts JL; Eltayeb AE; Demas DM; Warri AM; Facey CO; Hilakivi-Clarke LA; Clarke R
Mol Cancer; 2014 Oct; 13():239. PubMed ID: 25339305
[TBL] [Abstract][Full Text] [Related]
11. MYC-induced reprogramming of glutamine catabolism supports optimal virus replication.
Thai M; Thaker SK; Feng J; Du Y; Hu H; Ting Wu T; Graeber TG; Braas D; Christofk HR
Nat Commun; 2015 Nov; 6():8873. PubMed ID: 26561297
[TBL] [Abstract][Full Text] [Related]
12. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.
Wang R; Dillon CP; Shi LZ; Milasta S; Carter R; Finkelstein D; McCormick LL; Fitzgerald P; Chi H; Munger J; Green DR
Immunity; 2011 Dec; 35(6):871-82. PubMed ID: 22195744
[TBL] [Abstract][Full Text] [Related]
13. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling.
Yang C; Sudderth J; Dang T; Bachoo RM; McDonald JG; DeBerardinis RJ
Cancer Res; 2009 Oct; 69(20):7986-93. PubMed ID: 19826036
[TBL] [Abstract][Full Text] [Related]
14. c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis.
Arango D; Mariadason JM; Wilson AJ; Yang W; Corner GA; Nicholas C; Aranes MJ; Augenlicht LH
Br J Cancer; 2003 Nov; 89(9):1757-65. PubMed ID: 14583781
[TBL] [Abstract][Full Text] [Related]
15. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.
Gao P; Tchernyshyov I; Chang TC; Lee YS; Kita K; Ochi T; Zeller KI; De Marzo AM; Van Eyk JE; Mendell JT; Dang CV
Nature; 2009 Apr; 458(7239):762-5. PubMed ID: 19219026
[TBL] [Abstract][Full Text] [Related]
16. The TCA cycle transferase DLST is important for MYC-mediated leukemogenesis.
Anderson NM; Li D; Peng HL; Laroche FJ; Mansour MR; Gjini E; Aioub M; Helman DJ; Roderick JE; Cheng T; Harrold I; Samaha Y; Meng L; Amsterdam A; Neuberg DS; Denton TT; Sanda T; Kelliher MA; Singh A; Look AT; Feng H
Leukemia; 2016 Jun; 30(6):1365-74. PubMed ID: 26876595
[TBL] [Abstract][Full Text] [Related]
17. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism.
Dang CV
Cancer Res; 2010 Feb; 70(3):859-62. PubMed ID: 20086171
[TBL] [Abstract][Full Text] [Related]
18. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
Mukha A; Kahya U; Linge A; Chen O; Löck S; Lukiyanchuk V; Richter S; Alves TC; Peitzsch M; Telychko V; Skvortsov S; Negro G; Aschenbrenner B; Skvortsova II; Mirtschink P; Lohaus F; Hölscher T; Neubauer H; Rivandi M; Labitzky V; Lange T; Franken A; Behrens B; Stoecklein NH; Toma M; Sommer U; Zschaeck S; Rehm M; Eisenhofer G; Schwager C; Abdollahi A; Groeben C; Kunz-Schughart LA; Baretton GB; Baumann M; Krause M; Peitzsch C; Dubrovska A
Theranostics; 2021; 11(16):7844-7868. PubMed ID: 34335968
[TBL] [Abstract][Full Text] [Related]
19. Myc requires RhoA/SRF to reprogram glutamine metabolism.
Haikala HM; Marques E; Turunen M; Klefström J
Small GTPases; 2018 May; 9(3):274-282. PubMed ID: 27532209
[TBL] [Abstract][Full Text] [Related]
20. The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.
Yuneva MO; Fan TW; Allen TD; Higashi RM; Ferraris DV; Tsukamoto T; Matés JM; Alonso FJ; Wang C; Seo Y; Chen X; Bishop JM
Cell Metab; 2012 Feb; 15(2):157-70. PubMed ID: 22326218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
